Machine learning-based prediction of acute kidney injury after nephrectomy in patients with renal cell carcinoma.

Journal: Scientific reports
PMID:

Abstract

The precise prediction of acute kidney injury (AKI) after nephrectomy for renal cell carcinoma (RCC) is an important issue because of its relationship with subsequent kidney dysfunction and high mortality. Herein we addressed whether machine learning (ML) algorithms could predict postoperative AKI risk better than conventional logistic regression (LR) models. A total of 4104 RCC patients who had undergone unilateral nephrectomy from January 2003 to December 2017 were reviewed. ML models such as support vector machine, random forest, extreme gradient boosting, and light gradient boosting machine (LightGBM) were developed, and their performance based on the area under the receiver operating characteristic curve, accuracy, and F1 score was compared with that of the LR-based scoring model. Postoperative AKI developed in 1167 patients (28.4%). All the ML models had higher performance index values than the LR-based scoring model. Among them, the LightGBM model had the highest value of 0.810 (0.783-0.837). The decision curve analysis demonstrated a greater net benefit of the ML models than the LR-based scoring model over all the ranges of threshold probabilities. The application of ML algorithms improves the predictability of AKI after nephrectomy for RCC, and these models perform better than conventional LR-based models.

Authors

  • Yeonhee Lee
    Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Jiwon Ryu
    Biorobotics Laboratory, School of Mechanical and Aerospace Engineering, Seoul National University, Gwanak-ro 1, Gwanak-gu, Seoul 08826, Korea.
  • Min Woo Kang
    Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Kyung Ha Seo
    Medical Research Collaborating Center, Seoul National University Hospital, Seoul, South Korea.
  • Jayoun Kim
    Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Korea.
  • Jungyo Suh
    Department of Urology, Hospital Medicine Center, Seoul National University Hospital, Seoul, South Korea.
  • Yong Chul Kim
    Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Dong Ki Kim
    Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Kook-Hwan Oh
    Department of Internal Medicine, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
  • Kwon Wook Joo
    Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Yon Su Kim
    Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Chang Wook Jeong
    Department of Urology, Seoul National University Hospital, Seoul, Korea.
  • Sang Chul Lee
    2 Division of Plant Biosciences, Kyungpook National University, Daegu, Republic of Korea.
  • Cheol Kwak
    Department of Urology, Seoul National University, Seoul, Korea.
  • Sejoong Kim
    Department of Internal Medicine, Seoul National University College of Medicine, 103 Daehakro, Jongno-gu, Seoul, 03080, South Korea. sejoong2@snu.ac.kr.
  • Seung Seok Han
    Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.